Litcius/Paper detail

Long-term Oncological Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment

Pietro Scilipoti, Mattia Longoni, Mario de Angelis, Paolo Zaurito, Aleksander Ślusarczyk, Francesco Soria, Benjamin Pradère, Wojciech Krajewski, David D’Andrea, Andrea Mari, Francesco Del Giudice, Renate Pichler, José Daniel Subiela, Gautier Marcq, Andrea Gallioli, Luca Afferi, Riccardo Mastroianni, Giuseppe Simone, Simone Albisinni, Laura S. Mertens, Ekaterina Laukhtina, Katharina Oberneder, José Luis Rodríguez Elena, Javier Aranda, A. Lafuente Puentedura, J. Caño Velasco, Roberto Contieri, Rodolfo Hurle, Keiichiro Mori, Piotr Radziszewski, Shahrokh F. Shariat, Paolo Gontero, Andrea Necchi, Morgan Rouprêt, Francesco Montorsi, Andrea Salonia, Alberto Briganti, Marco Moschini

2025European Urology Focus15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBladder cancerBacillus (shape)OncologyUrologyBCG vaccineInternal medicineCancerPathologyTuberculosisMicrobiologyBiologyBladder and Urothelial Cancer TreatmentsImmune responses and vaccinationsUrinary and Genital Oncology Studies
Long-term Oncological Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment | Litcius